Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Unigene Lab. (UGNE) -- Ignore unavailable to you. Want to Upgrade?

To: flickerful who wrote (325)	6/23/1999 10:45:00 AM
From: Toni Wheeler	Read Replies (1) \| Respond to of 347

flick... thanks for the heads up on the patent announcement... A unique feature of the Company's oral delivery technology is its ability to routinely produce measurable blood levels of calcitonin in tested subjects, a property that is expected to facilitate the regulatory approval process. i would certainly prefer an oral med, if necessary to prevent further bone loss. Any ideas on when a) this FDA approval might be received? b)this product might be rolled out?? Anyone? Additionally, this ties in nicely with the recent approval of CMPD's hardware and software bone density measuring products. My best, ~T.